We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AARP Opposes 12-Year Exclusivity For Biologic Drugs In TPP

Law360, New York (October 24, 2013, 4:43 PM EDT) -- AARP Inc. said Tuesday that U.S. trade negotiators should not push for a provision in the Trans-Pacific Partnership that would allow brand-name biologic drugs to have exclusive access to the market...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.